Cargando…

Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment

BACKGROUND: Neoadjuvant (chemo) radiotherapy is used as a standard treatment for locally advanced rectal cancer (LARC), but there is no general consensus on either the efficacy of postoperative adjuvant chemotherapy in patients with LARC after neoadjuvant treatment and surgery, or whether the additi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jia-yi, Huang, Xuan-zhang, Gao, Peng, Chen, Xiao-wan, Song, Yong-xi, Lv, Xing-er, Fu, Yv, Xiao, Qiong, Wang, Zhen-ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319733/ https://www.ncbi.nlm.nih.gov/pubmed/34337057 http://dx.doi.org/10.1155/2021/8852699

Ejemplares similares

Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data
por: Li, Jia-yi, et al.
Publicado: (2021)

Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?
por: Gao, Peng, et al.
Publicado: (2014)

Impact of age on efficacy of postoperative oxaliplatin-based chemotherapy in patients with rectal cancer after neoadjuvant chemoradiotherapy
por: Huang, Xuan-zhang, et al.
Publicado: (2016)

Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
por: Akateh, Clifford, et al.
Publicado: (2019)

Total neoadjuvant treatment in locally advanced rectal cancer
por: De Felice, Francesca, et al.
Publicado: (2021)

Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?
por: Okamura, Ryosuke, et al.
Publicado: (2023)

Continuous Wound Infiltration with Local Anesthetic Is an Effective and Safe Postoperative Analgesic Strategy: A Meta-Analysis
por: Huang, Xuan-zhang, et al.
Publicado: (2021)

Adding Adjuvants to Fluoropyrimidine-based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: An Option Worthy of Serious Consideration
por: Wu, Fengpeng, et al.
Publicado: (2021)

Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
por: Zhang, Yiyi, et al.
Publicado: (2020)

Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer
por: Li, Zheng-Yan, et al.
Publicado: (2020)

Application of Radiomics in Predicting Treatment Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: Strategies and Challenges
por: Chen, Rui, et al.
Publicado: (2022)

Selection of Adjuvant Treatment Without Neoadjuvant Chemoradiotherapy for Patients With Rectal Cancer: Room for Further Investigation
por: Park, In Ja
Publicado: (2018)

Use of patient‐derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Xue, Weisong, et al.
Publicado: (2023)

Utility of Rectoscopy in the Assessment of Response to Neoadjuvant Treatment for Locally Advanced Rectal Cancer
por: Lopez-Lopez, Victor, et al.
Publicado: (2016)

Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer
por: Fu, Xing-Li, et al.
Publicado: (2017)

Reply: Adjuvant chemoradiotherapy is no alternative to intensified neoadjuvant chemoradiotherapy for local and systemic control in patients with locally advanced rectal cancer
por: Klautke, G, et al.
Publicado: (2006)

A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas
por: Yorio, Jeffrey T., et al.
Publicado: (2012)

Organ Preservation Strategies After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Yoo, Ri Na, et al.
Publicado: (2019)

Total neoadjuvant treatment and PD-1/PD-L1 checkpoint inhibitor in locally advanced rectal cancer
por: Xiao, Weiwei, et al.
Publicado: (2023)

Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis: Oxaliplatin in neoadjuvant treatment for rectal cancer
por: De Felice, Francesca, et al.
Publicado: (2017)

Neoadjuvant Treatment in Rectal Cancer: Actual Status
por: Garajová, Ingrid, et al.
Publicado: (2011)

Total Neoadjuvant Treatment of Locally Advanced Rectal Cancer with High Risk Factors in Slovenia
por: Tuta, Mojca, et al.
Publicado: (2019)

Complete response in patients with locally advanced rectal cancer after neoadjuvant treatment with nivolumab
por: Zhang, Jianwei, et al.
Publicado: (2019)

Organ Sparing for Locally Advanced Rectal Cancer after Neoadjuvant Treatment Followed by Electrochemotherapy
por: Rega, Daniela, et al.
Publicado: (2021)

Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview
por: Guida, Andrea M., et al.
Publicado: (2022)

Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
por: Papaccio, Federica, et al.
Publicado: (2020)

Strategies to Optimize Treatment for Locally Advanced Rectal Cancer
por: Hu, Xiaoyu, et al.
Publicado: (2022)

Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer
por: Ren, Dong-Lin, et al.
Publicado: (2019)

Prognostic Value of Interval Between the Initiation of Neoadjuvant Treatment to Surgery for Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy, Radiotherapy and Definitive Surgery
por: Wan, Xiang-Bo, et al.
Publicado: (2020)

Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
por: Crook, Christiana J., et al.
Publicado: (2023)

Wait-and-see treatment strategies for rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
por: Li, Jun, et al.
Publicado: (2016)

Should Local Excision After Neoadjuvant Therapy Be Included in the National Guidelines for the Treatment of Locally Advanced Rectal Cancer?
por: Aref, Amr, et al.
Publicado: (2022)

Efficacy of Imatinib Mesylate Neoadjuvant Treatment for a Locally Advanced Rectal Gastrointestinal Stromal Tumor
por: Yoon, Kyu Jong, et al.
Publicado: (2011)

Predictors of Definitive Treatment Interruptions of Long-Course Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Sapienza, Lucas G, et al.
Publicado: (2022)

Total Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients: Where Do We Stand?
por: Daprà, Valentina, et al.
Publicado: (2023)

Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy
por: Chang, Hui, et al.
Publicado: (2020)

Adjuvant chemotherapy for locally advanced rectal cancer in elderly patients after neoadjuvant chemoradiotherapy and surgery: Toxicity and survival outcomes
por: Sun, Quanquan, et al.
Publicado: (2020)

Neoadjuvant treatment of rectal cancer: where are we now?
por: Kalyan, Aparna, et al.
Publicado: (2016)

Clinical outcome of neoadjuvant chemoradiation in rectal cancer treatment
por: Suwanthanma, Weerapat, et al.
Publicado: (2021)

Impact of neoadjuvant treatment on rectal gastrointestinal stromal tumors
por: Cheong, Chinock, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mv648q2nuir26hqnj09198o9vg